Osaic Holdings’s Zivo Bioscience, Inc. Common Stock ZIVO Stock Holding History

Osaic Holdings’s Portfolio ZIVO Stock Details ZIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1	Closed	–	–	7392
2021 Q2	$0	Buy	+1	New	+$27	﹤0.01%	7191

Other funds holding ZIVO

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

VCA

Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bartlett & Co Cincinnati, Ohio $6.16B AUM 20.29% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.82B AUM 15.4% 1-Year Est. Return

Osaic Holdings's ZIVO Position: Q3 2021 in Review

Osaic Holdings sold out of Zivo Bioscience, Inc. Common Stock (ZIVO) in Q3 2021, closing a stake of 1 share.

Osaic Holdings first reported a position in ZIVO in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 12 funds tracked by Wall St. Rank hold ZIVO as of Q3 2021.

Osaic Holdings reported no remaining Zivo Bioscience, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Osaic Holdings sold 1 Zivo Bioscience, Inc. Common Stock share in Q3 2021.
Osaic Holdings first reported a position in Zivo Bioscience, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
Osaic Holdings's Zivo Bioscience, Inc. Common Stock position peaked at $0 in Q2 2021.
12 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Common Stock as of Q3 2021.

Based on Osaic Holdings's 13F filing for Q3 2021, filed 5 Nov 2021.